Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure
Abstract Aims Left atrial (LA) volume index (LAVI) in chronic heart failure (HF) predicts cardiovascular outcomes. However, the association between LAVI reduction during acute decompensated HF (ADHF) and its prognostic potential is limited. We hypothesized that LA reverse remodelling (LARR) after AD...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.15023 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850263552200278016 |
|---|---|
| author | Sakura Nagumo Mio Ebato Miki Tsujiuchi Takuya Mizukami Hideyuki Maezawa Ayumi Omura Megumi Kubota Maho Ohmi Yuki Numajiri Hitomi Kitai Tsutomu Toshida Yoshitaka Iso Hiroshi Suzuki |
| author_facet | Sakura Nagumo Mio Ebato Miki Tsujiuchi Takuya Mizukami Hideyuki Maezawa Ayumi Omura Megumi Kubota Maho Ohmi Yuki Numajiri Hitomi Kitai Tsutomu Toshida Yoshitaka Iso Hiroshi Suzuki |
| author_sort | Sakura Nagumo |
| collection | DOAJ |
| description | Abstract Aims Left atrial (LA) volume index (LAVI) in chronic heart failure (HF) predicts cardiovascular outcomes. However, the association between LAVI reduction during acute decompensated HF (ADHF) and its prognostic potential is limited. We hypothesized that LA reverse remodelling (LARR) after ADHF therapy would be associated with better clinical outcomes. Methods This retrospective study analysed clinical outcomes and the LAVI reduction rate of 363 out of 861 patients hospitalized for ADHF who underwent two‐point echocardiography at admission and discharge between January 2015 and December 2019. The mean age was 74.3 ± 13.6 years, and the mean ejection fraction (EF) was 38.9 ± 15.2%. The follow‐up echocardiogram was performed 13.0 [9.5, 20] days after admission. As the median LAVI reduction rate was 7.02%, the LARR was defined as an LAVI reduction rate >7%. Results During the 34.0 ± 20.2 months of follow‐up, 117 patients (32.2%) reached the primary endpoint defined as cardiovascular death and rehospitalization for ADHF. Kaplan–Meier survival analysis showed that patients with LARR had a better prognosis. Multivariate analysis indicated that LARR was an independent predictor of cardiovascular events. Similar findings were observed in the subgroup analyses of patients with persistent/permanent atrial fibrillation and those with non‐HF with reduced EF. Among patients who were brain natriuretic peptide (BNP) responders, defined as a relative reduction of >70% in BNP from admission to discharge, non‐LARR was observed in 41.6%. BNP responders without LARR experienced worse prognoses. Conclusions LARR in the early vulnerable phase after hospitalization for ADHF was associated with better long‐term clinical outcomes. |
| format | Article |
| id | doaj-art-6917af76d67d490c8fae2c06c9727392 |
| institution | OA Journals |
| issn | 2055-5822 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj-art-6917af76d67d490c8fae2c06c97273922025-08-20T01:54:57ZengWileyESC Heart Failure2055-58222024-12-011164285429510.1002/ehf2.15023Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failureSakura Nagumo0Mio Ebato1Miki Tsujiuchi2Takuya Mizukami3Hideyuki Maezawa4Ayumi Omura5Megumi Kubota6Maho Ohmi7Yuki Numajiri8Hitomi Kitai9Tsutomu Toshida10Yoshitaka Iso11Hiroshi Suzuki12Division of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Clinical Pharmacology, Department of Pharmacology Showa University Tokyo JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDepartment of Clinical Laboratory Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanDivision of Cardiology, Department of Internal Medicine Showa University Fujigaoka Hospital Yokohama JapanAbstract Aims Left atrial (LA) volume index (LAVI) in chronic heart failure (HF) predicts cardiovascular outcomes. However, the association between LAVI reduction during acute decompensated HF (ADHF) and its prognostic potential is limited. We hypothesized that LA reverse remodelling (LARR) after ADHF therapy would be associated with better clinical outcomes. Methods This retrospective study analysed clinical outcomes and the LAVI reduction rate of 363 out of 861 patients hospitalized for ADHF who underwent two‐point echocardiography at admission and discharge between January 2015 and December 2019. The mean age was 74.3 ± 13.6 years, and the mean ejection fraction (EF) was 38.9 ± 15.2%. The follow‐up echocardiogram was performed 13.0 [9.5, 20] days after admission. As the median LAVI reduction rate was 7.02%, the LARR was defined as an LAVI reduction rate >7%. Results During the 34.0 ± 20.2 months of follow‐up, 117 patients (32.2%) reached the primary endpoint defined as cardiovascular death and rehospitalization for ADHF. Kaplan–Meier survival analysis showed that patients with LARR had a better prognosis. Multivariate analysis indicated that LARR was an independent predictor of cardiovascular events. Similar findings were observed in the subgroup analyses of patients with persistent/permanent atrial fibrillation and those with non‐HF with reduced EF. Among patients who were brain natriuretic peptide (BNP) responders, defined as a relative reduction of >70% in BNP from admission to discharge, non‐LARR was observed in 41.6%. BNP responders without LARR experienced worse prognoses. Conclusions LARR in the early vulnerable phase after hospitalization for ADHF was associated with better long‐term clinical outcomes.https://doi.org/10.1002/ehf2.15023acute decompensated heart failureLA reverse remodellingLAVI |
| spellingShingle | Sakura Nagumo Mio Ebato Miki Tsujiuchi Takuya Mizukami Hideyuki Maezawa Ayumi Omura Megumi Kubota Maho Ohmi Yuki Numajiri Hitomi Kitai Tsutomu Toshida Yoshitaka Iso Hiroshi Suzuki Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure ESC Heart Failure acute decompensated heart failure LA reverse remodelling LAVI |
| title | Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure |
| title_full | Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure |
| title_fullStr | Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure |
| title_full_unstemmed | Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure |
| title_short | Prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure |
| title_sort | prognostic value of left atrial reverse remodelling in patients hospitalized with acute decompensated heart failure |
| topic | acute decompensated heart failure LA reverse remodelling LAVI |
| url | https://doi.org/10.1002/ehf2.15023 |
| work_keys_str_mv | AT sakuranagumo prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT mioebato prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT mikitsujiuchi prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT takuyamizukami prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT hideyukimaezawa prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT ayumiomura prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT megumikubota prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT mahoohmi prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT yukinumajiri prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT hitomikitai prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT tsutomutoshida prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT yoshitakaiso prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure AT hiroshisuzuki prognosticvalueofleftatrialreverseremodellinginpatientshospitalizedwithacutedecompensatedheartfailure |